Search

Viatris Inc

Cerrado

SectorSanidad

16.23 1.18

Resumen

Variación precio

24h

Actual

Mínimo

15.85

Máximo

16.26

Métricas clave

By Trading Economics

Ingresos

-295M

-119M

Ventas

240M

3.8B

BPA

0.69

Rentabilidad por dividendo

2.92

Margen de beneficios

-3.162

Empleados

30,000

EBITDA

9.4M

653M

Recomendaciones

By TipRanks

Recomendaciones

Neutral

Estimación a 12 Meses

+13.28% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

2.92%

2.22%

Próximas Ganancias

5 nov 2026

Fecha Próximo Dividendo

16 sept 2026

Próxima Fecha de Ex Dividendo

21 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1.8B

19B

Apertura anterior

15.05

Cierre anterior

16.23

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

163 / 340 Clasificación en Healthcare

Viatris Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 ago 2026, 20:06 UTC

Viatris Inc shares are higher today, despite earlier session pullbacks. Broader market sentiment is mixed following a decline in U.S. retail sales.

13 ago 2026, 20:06 UTC

Viatris Inc shares are lower today, reflecting broader market trends amid rising U.S. jobless claims that exceeded expectations. The stock remains near its one-month range low.

12 ago 2026, 23:06 UTC

Viatris Inc. shares moved higher in after-market trading, recovering from earlier losses. The stock remains below its 20-day moving average.

11 ago 2026, 23:41 UTC

Viatris Inc. shares rose in after-market trading, despite earlier fluctuations and broader market concerns about inflationary pressures and oil prices.

10 ago 2026, 19:42 UTC

Pharmaceuticals sector strength is lifting Viatris Inc during Monday's session, with increased trading volume contributing to the upward movement.

7 ago 2026, 22:01 UTC

Viatris Inc. shares are higher in after-market trading, supported by a broader equity rally following weaker employment data and reduced interest rate hike concerns.

6 ago 2026, 23:01 UTC

Viatris Inc shares are higher in after-market hours, recovering from earlier lows. The stock is trading above Thursday's close despite recent declines.

5 ago 2026, 23:11 UTC

Viatris Inc. shares are trading higher in after-market hours, recovering significantly above the 20-day moving average amid broader market optimism despite no specific news.

4 ago 2026, 23:06 UTC

Viatris Inc shares are higher in after-market trading, reflecting positive momentum and positioning above the 20-day moving average. No specific news was identified.

3 ago 2026, 20:06 UTC

Viatris Inc shares are higher today, reflecting broader market gains led by major stocks. The S&P 500 and Nasdaq 100 have also risen.

31 jul 2026, 21:02 UTC

Viatris Inc shares are lower in after-market hours, continuing a four-session decline amid rising inflation concerns and higher crude oil prices.

30 jul 2026, 18:56 UTC

Event

Viatris shares are trading lower despite FDA approval of the Gwyn Lo contraceptive patch. Broader economic data may be impacting the stock's performance.

29 jul 2026, 22:03 UTC

Event

Viatris Inc. shares are lower in after-market hours despite FDA approval of the Gwyn Lo contraceptive patch, amid broader market caution over geopolitical tensions.

28 jul 2026, 19:36 UTC

Social Media

Viatris shares are higher today, supported by strong sector gains and a significant rise in January 2027 $10 call options activity.

27 jul 2026, 19:11 UTC

Viatris Inc shares are higher today, breaking a trend of daily gains. No specific news was identified to explain this movement.

23 jul 2026, 20:06 UTC

Viatris Inc's shares are higher during Thursday's session, continuing an upward trend since Wednesday's close. No specific news was identified to explain the movement.

22 jul 2026, 23:16 UTC

Viatris Inc shares are higher in after-market hours, recovering from an earlier dip and reflecting strength amid rising crude oil prices.

21 jul 2026, 18:46 UTC

Viatris Inc shares are higher today, rebounding after an earlier dip amid a broader recovery in U.S. markets and renewed investor optimism.

20 jul 2026, 19:21 UTC

News

Viatris Inc shares are lower amid negative sentiment in the Pharmaceuticals sector. Analysts cite a price target of $17.81, reflecting concerns over sales declines.

Comparación entre iguales

Cambio de precio

Viatris Inc previsión

Precio Objetivo

By TipRanks

13.28% repunte

Estimación a 12 Meses

Media 18.17 USD  13.28%

Máximo 23 USD

Mínimo 12 USD

De acuerdo con 6 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Viatris Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Neutral

6 ratings

2

Comprar

3

Mantener

1

Vender

Sentimiento

By Acuity

163 / 340 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat